These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12544349)
1. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. Zhao H; Grossman HB; Spitz MR; Lerner SP; Zhang K; Wu X J Urol; 2003 Feb; 169(2):714-7. PubMed ID: 12544349 [TBL] [Abstract][Full Text] [Related]
2. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. Oh JC; Wu W; Tortolero-Luna G; Broaddus R; Gershenson DM; Burke TW; Schmandt R; Lu KH Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850 [TBL] [Abstract][Full Text] [Related]
4. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047 [TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer. Serrano ML; Romero A; Cendales R; Sánchez-Gómez M; Bravo MM Biomedica; 2006 Jun; 26(2):258-68. PubMed ID: 16925098 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factors and breast cancer risk in Chinese women. Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix. Wu X; Tortolero-Luna G; Zhao H; Phatak D; Spitz MR; Follen M Clin Cancer Res; 2003 Aug; 9(9):3356-61. PubMed ID: 12960122 [TBL] [Abstract][Full Text] [Related]
9. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin. Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247 [TBL] [Abstract][Full Text] [Related]
10. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study. Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200 [TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk. Nam RK; Trachtenberg J; Jewett MA; Toi A; Evans A; Emami M; Narod SA; Pollak M Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1270-3. PubMed ID: 15894684 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475 [TBL] [Abstract][Full Text] [Related]
13. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide. Decensi A; Veronesi U; Miceli R; Johansson H; Mariani L; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Costa A; Perloff M; Malone WF; Formelli F Clin Cancer Res; 2003 Oct; 9(13):4722-9. PubMed ID: 14581342 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584 [TBL] [Abstract][Full Text] [Related]
15. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort. Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261 [TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men. Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996 [TBL] [Abstract][Full Text] [Related]
17. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer. Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172 [TBL] [Abstract][Full Text] [Related]
18. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study. Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911 [TBL] [Abstract][Full Text] [Related]
19. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men. Kehinde EO; Akanji AO; Mojiminiyi OA; Bashir AA; Daar AS; Varghese R Prostate Cancer Prostatic Dis; 2005; 8(1):84-90. PubMed ID: 15775992 [TBL] [Abstract][Full Text] [Related]
20. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer. Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]